Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Argo Blockchain plc

Start price
Target price
Perf. (%)
€3.02
07.03.21
-
07.03.22
-76.49%
08.03.22

EBIT growth >5% per year expected
Capable Management
Growths faster than the competition
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€25.01
07.03.21
€40.00
07.03.22
-20.82%
08.03.22

Growths faster than the competition
Medium risks for its business
buy
McPhy Energy S.A.

Start price
Target price
Perf. (%)
€27.40
07.03.21
€32.00
07.03.22
-41.93%
08.03.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Top Rating
buy
Computer Programs + Sys

Start price
Target price
Perf. (%)
€25.80
07.03.21
-
07.03.22
18.60%
08.03.22

Risky Investment
buy
iSun Inc.

Start price
Target price
Perf. (%)
€9.36
07.03.21
-
07.03.22
-41.65%
08.03.22

Risky Investment
buy
Ur-Energy Inc.

Start price
Target price
Perf. (%)
€0.88
07.03.21
€3.00
07.03.22
78.61%
08.03.22

Market Leader or Top 3
Very Future proof/growth oriented business model
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€28.67
07.03.22
€21.00
07.03.23
-33.73%
07.03.22

Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€6.20
21.02.22
€13.50
21.02.23
2.90%
07.03.22

Could be very worthwhile Investment >20% year
buy
ION Geophysical Corp.

Start price
Target price
Perf. (%)
€0.48
25.02.22
€1.00
25.02.23
156.28%
07.03.22

Could be very worthwhile Investment >20% year
buy
Arcimoto Inc

Start price
Target price
Perf. (%)
€6.22
02.03.22
€12.00
02.03.23
-4.82%
07.03.22

Could be very worthwhile Investment >20% year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
buy
HighPoint Resources Corp.

Start price
Target price
Perf. (%)
€7.96
06.03.21
-
06.03.22
-41.52%
07.03.22

Could be worthwhile Investment >10% per year
buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€2.60
06.03.21
-
06.03.22
-73.65%
07.03.22

Could be very worthwhile Investment >20% year
buy
Psi AG

Start price
Target price
Perf. (%)
€33.50
21.02.22
€40.00
21.02.23
-2.69%
05.03.22

Standard Investments for future growth
Innovative
Future proof or reliable business model
Significant cyclical dependencies
buy
MBB SE

Start price
Target price
Perf. (%)
€120.60
21.02.22
€130.00
21.02.23
-10.78%
05.03.22

Standard Investments for future growth
Differentiated customer and product portfolio
Higher risks for its business
Significant cyclical dependencies
buy
Takkt AG

Start price
Target price
Perf. (%)
€15.04
02.03.22
€17.00
02.03.23
-1.46%
05.03.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
buy
2G Energy AG

Start price
Target price
Perf. (%)
€103.40
02.03.22
€110.00
02.03.23
-8.03%
05.03.22

Top 10 in its market
Revenue growth >5% per year expected
Sustainability is very important
Significant cyclical dependencies
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.31
20.02.22
-
20.02.23
-6.49%
05.03.22

Risky Investment
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€11.05
20.02.22
-
20.02.23
-1.99%
05.03.22

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€29.39
20.02.22
-
20.02.23
-0.65%
05.03.22

Could be very worthwhile Investment >20% year
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.70
20.02.22
-
20.02.23
-18.09%
05.03.22

Could be very worthwhile Investment >20% year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.03
22.02.22
€1.00
22.02.23
-25.24%
05.03.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Wasgau Produktions & Handels AG

Start price
Target price
Perf. (%)
€14.60
19.02.22
-
19.02.23
-2.05%
05.03.22

Top 10 in its market
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
BayWa AG VNA

Start price
Target price
Perf. (%)
€36.90
19.02.22
-
19.02.23
-2.44%
05.03.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Aixtron SE

Start price
Target price
Perf. (%)
€18.10
03.03.21
-
03.03.22
2.79%
04.03.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation